TERT genetic polymorphism rs2736100 was associated with lung cancer: A meta-analysis based on 14,492 subjects

Genetic Testing and Molecular Biomarkers

Volumn 17, Issue 12, 2013, Pages 937-941

  Wang, Hui Min ^a   Zhang, Xue Yan ^a   Jin, Bo ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER RISK; DATA BASE; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; LUNG CANCER; PUBLISHING; SENSITIVITY ANALYSIS; TELOMERASE REVERSE TRANSCRIPTASE GENE;

CASE-CONTROL STUDIES; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MODELS, GENETIC; NEOPLASM PROTEINS; PUBMED; RISK FACTORS; TELOMERASE;

EID: 84889041841     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2013.0322     Document Type: Article

References (21)

1. Bae EY, Lee SY, Kang BK, et al. (2012) Replication of results of genome-wide association studies on lung cancer susceptibility loci in a Korean population. Respirology 17:699-706.
2. Baird DM (2010) Variation at the TERT locus and predisposition for cancer. Expert Rev Mol Med 12:e16.
3. Bianchi A, Shore D (2008) How telomerase reaches its end: mechanism of telomerase regulation by the telomeric complex. Mol Cell 31:153-165. (Pubitemid 352005819)
4. Brenner DR, Brennan P, Boffetta P, et al. (2013) Hierarchical modeling identifies novel lung cancer susceptibility variants in inflammation pathways among 10,140 cases and 11,012 controls. Hum Genet 132:579-589.
5. Carpentier C, Lejeune J, Gros F, et al. (2007) Association of telomerase gene hTERT polymorphism and malignant gliomas. J Neurooncol 84:249-253. (Pubitemid 47108517)
6. Chen W, Zhang S, Zou X (2010) Evaluation on the incidence, mortality and tendency of lung cancer in China. Thorac Cancer 1:35-40.
7. Chen XF, Cai S, Chen QG, et al. (2012) Multiple variants of TERT and CLPTM1L constitute risk factors for lung adenocarcinoma. Genet Mol Res 11:370-378.
8. Hunter DJ, Kraft P, Jacobs KB, et al. (2007) A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet 39: 870-874. (Pubitemid 47014500)
9. Kiyohara C, Otsu A, Shirakawa T, et al. (2002) Genetic polymorphisms and lung cancer susceptibility: a review. Lung Cancer 37:241-256. (Pubitemid 35286722)
10. Landi MT, Chatterjee N, Yu K, et al. (2009) A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am J Hum Genet 85:679-691.
11. Miki D, Kubo M, Takahashi A, et al. (2010) Variation in TP63 is associated with lung adenocarcinoma susceptibility in Japanese and Korean populations. Nat Genet 42:893-896.
12. Myneni AA, Chang SC, Niu R, et al. (2013) Genetic polymorphisms of TERT and CLPTM1L and risk of lung cancer-a casecontrol study in a Chinese population. Lung Cancer 80:131-137.
13. Osterhage JL, Friedman KL (2009) Chromosome end maintenance by telomerase. J Biol Chem 284:16061-16065.
14. Sagoo GS, Little J, Higgins JP (2009) Systematic reviews of genetic association studies. Human Genome Epidemiology Network. PLoS Med 6:e28.
15. Savage SA, Chanock SJ, Lissowska J, et al. (2007) Genetic variation in five genes important in telomere biology and risk for breast cancer. Br J Cancer 97:832-836. (Pubitemid 47396285)
16. Shields PG, Harris CC (2000) Cancer risk and low-penetrance susceptibility genes in gene-environment interactions. J Clin Oncol 18:2309-2315. (Pubitemid 30350224)
17. Taylor J, Tyekucheva S, King DC, et al. (2006) ESPERR: learning strong and weak signals in genomic sequence alignments to identify functional elements. Genome Res 16:1596-1604. (Pubitemid 44878498)
18. Wang L, Soria JC, Chang YS, et al. (2003) Association of a functional tandem repeats in the downstream of human telomerase gene and lung cancer. Oncogene 22:7123-7129. (Pubitemid 37378544)
19. Wang Y, Broderick P, Matakidou A, et al. (2010) Role of 5p15.33 (TERT-CLPTM1L), 6p21.33 and 15q25.1 (CHRNA5-CHRNA3) variation and lung cancer risk in never-smokers. Carcinogenesis 31:234-238.
20. Wang Y, Kuan PJ, Xing C, et al. (2009) Genetic defects in surfactant protein A2 are associated with pulmonary fi brosis and lung cancer. Am J Hum Genet 84:52-59.
21. Yeager M, Orr N, Hayes RB, et al. (2007) Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet 39:645-649. (Pubitemid 46676108)